Chronic hepatitis B
Do you want to receive a message when there is new research about Chronic hepatitis B? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication there is one sentence that explains what was investigated — and you receive a message as soon as there is new research about Chronic hepatitis B. View what Premium costs.
Publications and studies (2004)
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B (2026-01-09) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C (2026-01-06) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B (2026-01-06) ♡
- Unexpectedly low prevalence of hepatitis delta virus infection in Southern Viet Nam. (2025/12/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatic Macrophages in Chronic Hepatitis B: Balancing Immunity and Pathology. (2025/12/31) ♡
- Low adherence of guideline-based monitoring among chronic hepatitis B patients: a mixed quantitative and qualitative study. (2025/12/31) ♡
- Serum Bile Acid Profiling Across the Full Spectrum of HBV-Related Liver Diseases in Chinese Population: Implications for Diagnosis and Treatment Assessment. (2025/12/31) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Subacute cutaneous lupus erythematosus in a patient with Whipple's disease. (2025/12/30) ♡
- Complete chloroplast genome sequence of Silene jenisseensis, Arenaria juncea, and Gypsophila licentiana: gene organization, comparative analysis, and phylogenetic relationships. (2025/12/30) ♡
- Nationwide Prevalence of Hepatocellular Carcinoma in Saudi Arabia: A Population-Based Analysis for 2021. (2025/12/30) ♡
- Association Between SGLT2 Inhibitor Use and Reduced Risk of Liver-Related Events, Including Hepatocellular Carcinoma, in Diabetic Patients with Viral Hepatitis: A Nationwide Cohort Study. (2025/12/30) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Longitudinal Profile of HBsAg Isoforms and Circulating Immune Complexes in the Natural History of Chronic Hepatitis B Infection. (2025/12/28) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical, pathological characteristics and long-term outcomes of hepatitis B virus related cirrhosis in pediatric observational study. (2025/12/28) ♡
- Triterpenoids CDDO and CDDO-EA Inhibit the Replication of Hepatitis B Virus by Modulating Nucleocapsid Assembly. (2025/12/27) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. The impact of chronic hepatitis B and chronic hepatitis C on sexual function: a systematic review and meta-analysis. (2025/12/26) ♡
- Orocervical Actinomycosis in a Patient With Neck Swelling and Occipital Headache: A Case Report. (2025/12/26) ♡
- Social Determinants of Health and Quality of Life Among Korean Americans with Chronic Hepatitis B. (2025/12/26) ♡
- Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D). (2025/12/26) ♡
- Serum N-glycomics for non-invasive detection of significant liver pathology across clinical phases of treatment-naïve chronic hepatitis B. (2025/12/25) ♡
- Adherence to antiviral treatment among people living with chronic hepatitis B: A global survey. (2025/12/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advancing Hepatocellular Carcinoma Therapy with Next-Generation Molecular and Immunotherapeutics. (2025/12/24) ♡
- Effects of Non-Alcoholic Fatty Liver Disease on Baseline Histology and 96-Week Entecavir Response in Treatment-Naïve Chronic Hepatitis B. (2025/12/23) ♡
- Anxiety and Depression Among Hepatitis B Inpatients in Shenzhen, China: A Cross-Sectional Study. (2025/12/23) ♡
- Unusual Concurrent HBsAg and Anti-HBs Positivity in Chronic Hepatitis B with Compensated Cirrhosis. (2025/12/23) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Maternal Listeriosis Presenting With Suspected Meningitis in Late Pregnancy: A Case Report. (2025/12/22) ♡
- Peripheral and intrahepatic B-cell subsets contribute to HBeAg seroconversion in patients with chronic hepatitis B. (2025/12/20) ♡
- [Analysis of antiviral efficacy in pediatric patients with HBeAg-negative chronic hepatitis B]. (2025/12/20) ♡
- [Construction of a highly efficient HBV infection cell model based on HBV co-receptor neuropilin-1]. (2025/12/20) ♡
- [Reflections on the novel definition and whether or not antiviral therapy for inactive HBsAg carrier state in the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)"]. (2025/12/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Clinical research advances for small-molecule nucleic acid drugs in the treatment of chronic hepatitis B]. (2025/12/20) ♡
- Interferon therapy-induced reduction in PD-1 + CD8 + and CD160 + CD8 + T cells is associated with functional cure in hepatitis B. (2025/12/19) ♡
- IL-21 attenuates liver inflammation by enhancing myeloid-derived suppressor cells immunosuppressive function in chronic HBV infection. (2025/12/19) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Efficacy and safety of PEG-IFN α-2b and tenofovir amibufenamide in combination therapy for chronic hepatitis B. (2025/12/19) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Effects of different therapeutic methods on the 90-day prognosis of patients with HBV-ACLF: A systematic review and network meta-analysis. (2025/12/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Adefovir dipivoxil-induced Fanconi syndrome associated with hypophosphatemic osteomalacia misdiagnosed as cervical spondylotic myelopathy: A case report and literature review. (2025/12/19) ♡
- Utility of Biomarker Panels in the Surveillance and Monitoring of Hepatocellular Carcinoma: Consensus Statements from an International Delphi Panel. (2025/12/19) ♡
- Rhino-Orbital-Cerebral Mucormycosis in a Patient With Chronic Hepatitis B and D Coinfection: A Rare Case Report. (2025/12/17) ♡
- Entecavir provides favorable virological control but minimal metabolic benefit in patients with Chronic Hepatitis B and MAFLD. (2025/12/15) ♡
- Identification of serum MicroRNAs associated with hepatic immunoinflammatory injury in chronic hepatitis B: implications for non-invasive diagnosis. (2025/12/11) ♡
- Hepatitis B Surface Antibody Clearance After Vaccination in People With HIV. (2025/12/11) ♡
- The association between intrahepatic malignant tumors and hepatitis B-related pathological cirrhosis: a retrospective cohort study. (2025/12/09) ♡
- Systemic immune-inflammation index as a predictor of all-cause mortality in patients with hepatitis B virus infection: A cross-sectional study based on NHANES 1999 to 2018. (2025/12/05) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Proteome profiling of extracellular vesicles-derived from hepatitis B virus-infected hepatocellular carcinoma cell lines identifies PDCD11 as a carrier of viral RNAs. (2025/12/05) ♡
- Discontinuation of nucleos(t)ide analogues after NA-induced HBsAg seroclearance: a single-center 48-week retrospective study. (2025/12/04) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Transarterial Radioembolization (TARE) Complicated by a Mycotic Aneurysm and Bleeding: A Case Presentation and Literature Review. (2025/12/04) ♡
- Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis B. (2025/12/04) ♡
- Chronic hepatitis B coinfection and survival in pediatric T-ALL: A propensity-matched analysis. (2025/12/03) ♡
- Etiology of nephrotic syndrome: insights from univariate and multivariate Mendelian randomization study. (2025/12/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus. (2025/12/01) ♡
- Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B. (2025/12/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.